Biosort Secures More Than NOK 100 Million to Commercialize Individual-Based Lice Control

Biosort Secures More Than NOK 100 Million to Commercialize Individual-Based Lice Control

Biosort, best known for the development license project iFarm, has secured more than NOK 100 million from a strong group of aquaculture and technology investors to bring its individual-based lice control system to market.

Investors include Grieg Kapital, Hatch Blue, IVC, Farvatn, and Futurum Ventures, together with existing owners.

The capital will support final development and market introduction of Biosort’s next-generation, lice control technology.  The system is designed to efficiently remove lice at an early stage, preventing uncontrolled lice population growth and reducing the need for full-pen interventions.

“This funding takes us from development into commercial sales. Our focus is simple: continuous lice removal to suppress lice development and greatly reduce needs for well-boat treatments. The goal is improved welfare, lower mortality, better biological control, and ultimately making fish thrive.” said Geir Stang Hauge, CEO of Biosort.

Founded in 2010, Biosort has developed advanced machine vision, AI, and FishID technology capable of identifying and tracking individual salmon. The system now combines early lice removal with data on individual fish.

“We have followed Biosort for several years and are impressed by the team and their technology. Sea lice remain one of the greatest challenges in salmon farming, and Biosort’s approach has the potential to improve both lice management and fish health. We are excited to support the company as it moves into commercialization,” said Stian Grieg, Investment Manager at Grieg Kapital.

“There is a clear shift in the salmon industry toward stronger focus on fish health and greater adoption of new technology. Through Blue Revolution Fund, we invest in next-generation aquaculture solutions that improve health and sustainability. Together with a strong and experienced investor consortium, we believe Biosort is well positioned to contribute to the next phase of salmon farming,” said Carsten Krome, Managing Partner at Hatch Blue.

Related Posts

New Landmark Report on Germany’s Untapped Potential in Aquaculture by Hatch Blue and Rentenbank

New Landmark Report on Germany’s Untapped Potential in Aquaculture by Hatch Blue and Rentenbank

Engineering the Blue Future: Germany’s Role in European Aquaculture Tech, a new report conducted by Hatch Blue and commissioned by Landwirtschaftliche Rentenbank, outlines how Germany could turn research strengths into aquaculture technology leadership.
Blue Catalyst Unveils Inaugural Cohort to Advance Blue Carbon Solutions in Southeast Asia

Blue Catalyst Unveils Inaugural Cohort to Advance Blue Carbon Solutions in Southeast Asia

Today, the Blue Catalyst Challenge takes a major step forward in catalysing technological solutions for high-quality blue carbon ecosystems. Hatch Blue and the World Wide Fund for Nature (WWF) Singapore, supported by the Singapore Economic Development Board (EDB), are proud to introduce the 10 early-stage ventures selected for the inaugural cohort.
Hatch Blue Launches First Region-Wide Seaweed Intelligence Platform for Latin America and the Caribbean

Hatch Blue Launches First Region-Wide Seaweed Intelligence Platform for Latin America and the Caribbean

Hatch Blue has launched an expanded Seaweed Insights platform, delivering the first region-wide, data-driven view of the macroalgae sector across Latin America and the Caribbean (LAC).
Builders Vision Takes Strategic GP Stake in Hatch Blue, Signaling Global Confidence in Aquaculture’s Next Growth Phase

Builders Vision Takes Strategic GP Stake in Hatch Blue, Signaling Global Confidence in Aquaculture’s Next Growth Phase

Hatch Blue, a global investment firm specializing in aquaculture, today announced a strategic minority General Partner investment from Builders Vision - the investment and philanthropy platform founded by Lukas Walton.